Sidroga Emser hypertonic, Emser 8% hyperton 20x 5ml Sidroga

 Emser Inhalation Solution hypertonic 8% is a sterile aqueous solution of natural Emser salt in a strongly hypertonic concentration for inhalation using a nozzle or a compressed air nebulizer, an ultrasonic nebulizer or a nebulizer with an oscillating membrane. For inhalation for the purpose of an osmotically induced intensive increase in secretion mobilization. The tonicity of the Emser hypertonic inhalation solution 8% corresponds to a tonic solution of NaCl 6%. 100 ml of solution contains: 8.13 g of natural Emser salt, purified water. Natural Ems salt is a complex salt mixture with a high proportion of hydrogen carbonate (bicarbonate). In addition, it contains numerous minerals and trace elements that are important for the human body (ion analysis data in g / kg: lithium 0.21, sodium 308.7, potassium 6.11, magnesium 0.291, calcium 0.016, manganese 0.0001, iron (II, III) 0.003, fluoride 0.078, chloride 188.4, bromide 0.202, iodide 0.005, nitrate 0.355, sulfate 9.24, hydrogen carbonate 474.4, carbonate 14.0). Due to its osmotic effect, Emser Inhalation Solution hypertonic 8% provides an intensive increase in secretion mobilization with simultaneous liquefaction of mucus due to the hypertonic solution. The activity of ciliated cells is stimulated. For example, Emser Inhalation Solution Hypertonic 8% naturally supports the self-cleaning mechanism of the airways, which has a positive effect on inflammation. Emser Inhalation Solution Hypertonic 8% should not be used if shortness of breath has occurred during previous inhalation with hypertonic saline solutions, if there are known intolerances (allergies) to the ingredients or in case of coughing up blood (hemoptysis). There is no evidence against the use of Emser Inhalation Solution Hypertonic 8% during pregnancy and breastfeeding. Children, adolescents and adults should inhale Emser Inhalation Solution Hypertonic 8% 3 to 4 times a day, 5 ml of the solution inhaled with each inhalation. Before inhalation, Emser hypertonic inhalation solution should be brought to 8% at room temperature. Inhalation should always be carried out using a suitable nebulizer device. Suitable electric nebulizers (ultrasonic nebulizers, nozzle or air nebulizers or nebulizers with a swaying diaphragm). Side effects when inhaling Emser Inhalation Solution Hypertonic 8% in patients with bronchial asthma and hyperreactive bronchial system in individual cases may include spasmodic narrowing of the bronchi with acute dyspnea, if the dyspnea does not pass in individual cases, temporary irritation (cough) or cardiovascular problems (such as bradycardia or increased blood pressure) may also occur.